IFG Advisory’s Ionis Pharmaceuticals IONS Stock Holding History

IFG Advisory’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$212K	Buy	+2,678	New	+$202K	0.01%	852
2026 Q1	–	Sell	-2,678	Closed	-$212K	–	612
2025 Q4	$212K	Buy	+2,678	New	+$202K	0.01%	722
2019 Q3	–	Sell	-4,073	Closed	-$261K	–	421
2019 Q2	$261K	Buy	4,073 +58	+1%	+$4.1K	0.05%	295
2019 Q1	$325K	Sell	4,015 -374	-9%	-$24.1K	0.06%	256
2018 Q4	$237K	Buy	4,389 +21	+0.5%	+$1.07K	0.06%	274
2018 Q3	$225K	Buy	+4,368	New	+$205K	0.04%	344
2018 Q2	–	Sell	-4,920	Closed	-$216K	–	350
2018 Q1	$216K	Sell	4,920 -50	-1%	-$2.54K	0.05%	314
2017 Q4	$249K	Buy	+4,970	New	+$273K	0.06%	285

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

IFG Advisory's IONS Position: Q2 2026 in Review

IFG Advisory opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 2,678 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #852 among its holdings. This is a return to the name: IFG Advisory previously reported a position in IONS as recently as Q4 2025.

IFG Advisory first reported a position in IONS in Q4 2017 and has held it in 8 quarters since. The position peaked at $325K in Q1 2019. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

IFG Advisory held 2,678 shares of Ionis Pharmaceuticals worth $212K as of Q2 2026.
Ionis Pharmaceuticals was a new IFG Advisory position in Q2 2026.
Ionis Pharmaceuticals made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #852 holding.
IFG Advisory first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
IFG Advisory's Ionis Pharmaceuticals position peaked at $325K in Q1 2019.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.